Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus.
D000293:Adolescent; D000328:Adult; D001778:Blood Coagulation Disorders / Q000150:complications / Q000188:drug therapy / Q000209:etiology*; D001779:Blood Coagulation Factors / Q000032:analysis; D001791:Blood Platelet Disorders / Q000150:complications; D005164:Factor IX; D005172:Factor XI; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000150:complications; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011517:Prothrombin Time
D001779:Blood Coagulation Factors; D007166:Immunosuppressive Agents; D005164:Factor IX; D005172:Factor XI; D011241:Prednisone